I agree to the use of cookies and have read and understood SPT Labtech’s privacy policy.

Resources (444)

Cell-based assays, Cell-based assay screening

Lee et al., High-throughput screening for genes that prevent excess DNA replication in human cells and for molecules that inhibit them. Methods, Eprint 5th April 2012

Cell-based assay screening

Gerlinger et al., Genome‐wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. J. Pathol 2012 Feb 24

Cell-based assays, Cell-based assay screening

Heald et al., Discovery of Novel Allosteric Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors Possessing Bidentate Ser212 Interactions. J. Med. Chem. 2012, 55, 4594−4604

Compound management

Gaisford, W. (2012) The future of sample management: Part 1. Pharma July/August p43

mosquito HV genomics

Gaisford, W. (2012) Robotic liquid handling and automation in epigenetics. JALA

Hanging drop crystallization

Koide, A., J. Wojcik, et al. (2012). Teaching an Old Scaffold New Tricks: Monobodies Constructed Using Alternative Surfaces of the FN3 Scaffold. J Mol Biol 415(2): 393-405.

Sitting drop crystallization

Brelidze, T. I. et al (2012) Structure of the carboxy-terminal region of a KCNH channel. Nature 481: 530–533

Cell-based assays, Cell-based assay screening

Gaisford, W. Evolving methods in cytology: its the era of laser scanning, imaging-based technology. MLO, Dec 2011

Cell-based assays

Zhao, G et al. A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows A Potent Broad-spectrum of Anti-tumor Activity in Several Tumor Xenograft Models. MCT, Sept 2011.

Cell-based assays

Meier, T et al. Tasisulam Sodium, an Anti-tumor Agent that Inhibits Mitotic Progression and Induces Vascular Normalization. MCT, Sept 2011.

Cell-based assays

Meyvantsson et al., Image-based analysis of primary human neutrophil chemotaxis in an automated direct-viewing assay. J. Immunol. Methods. 2011 Nov 30;374 (1-2):70-7

Cell-based assays

Lu et al. 2011. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene. Mol. Cancer Ther. 10(1):80-9.

Interested? Get in touch to start the journey

Find help through our cross-domain support package

Find out where you can see our technologies in action

Get up to speed with our news